Number of shares outstanding for Eagle Pharmaceuticals (EGRX)

Number of shares outstanding as of December 2025 : 13,090,852

According to Eagle Pharmaceuticals 's latest financial reports and stock price the company's current number of shares outstanding is 13,090,852. At the end of 2023 the company had 13,090,852 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Eagle Pharmaceuticals from 2012 to 2023

Shares Outstanding at the end of each year

Year	Shares Outstanding	Change
2023	13.09 M	0.58%
2022	13.01 M	0.93%
2021	12.89 M	-4.69%
2020	13.53 M	-0.84%
2019	13.64 M	-5.02%
2018	14.36 M	-3.52%
2017	14.89 M	-2.63%
2016	15.29 M	-1.95%
2015	15.59 M	11.16%
2014	14.03 M	0.82%
2013	13.91 M	31.7%
2012	10.56 M

Shares Outstanding for similar companies or competitors

Company	Shares Outstanding	differencediff.	Country
Johnson & Johnson JNJ	2,406,195,000	18,280.74%	🇺🇸 USA
GlaxoSmithKline GSK	2,017,000,000	15,307.71%	🇬🇧 UK
Novartis NVS	1,926,000,000	14,612.56%	🇨🇭 Switzerland
Teva Pharmaceutical Industries TEVA	1,147,000,000	8,661.84%	🇮🇱 Israel
Amgen AMGN	538,000,000	4,009.74%	🇺🇸 USA
Eli Lilly LLY	895,841,000	6,743.26%	🇺🇸 USA
Bristol-Myers Squibb BMY	2,036,000,000	15,452.85%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions